Merck & Co

New Moderna Vaccine Delays Skin Cancer Recurrence, Reduces Risk of Death by 44%

An experimental mRNA vaccine developed by Moderna Inc, combined with Merck & Co immunotherapy, reduced the risk of death or…

3 years ago